MiR-3663-3p participates in the anti-hepatocellular carcinoma proliferation activity of baicalein by targeting SH3GL1 and negatively regulating EGFR/ERK/NF-?B signaling

Tian, J; Li, J; Bie, BB; Sun, J; Mu, YH; Shi, MJ; Zhang, SQ; Kong, GY; Li, ZF; Guo, Y

Li, ZF; Guo, Y (corresponding author), Xi An Jiao Tong Univ, Natl & Local Joint Engn Res Ctr Biodiag & Biother, Affiliated Hosp 2, Xian 710004, Shaanxi, Peoples R China.

TOXICOLOGY AND APPLIED PHARMACOLOGY, 2021; 420 ():